Cargando…

Tailored Telemonitoring in patients with heart failure: results from a multicentre randomized controlled trial (the TEHAF-study)

BACKGROUND: Recent increasing prevalence of heart failure (HF) patients leads to an increasing burden to the health care system. Consequently, there is a need for innovative strategies to reduce HF hospitalizations. METHODS: We performed a multicentre randomized controlled trial to test the hypothes...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyne, Josiane, Vrijhoef, Hubertus, Crijns, Harry, Nieman, Fred, Deweerd, Gerjan, Kragten, Johannes, Gorgels, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Igitur, Utrecht Publishing & Archiving 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571195/
_version_ 1782259151491039232
author Boyne, Josiane
Vrijhoef, Hubertus
Crijns, Harry
Nieman, Fred
Deweerd, Gerjan
Kragten, Johannes
Gorgels, Anton
author_facet Boyne, Josiane
Vrijhoef, Hubertus
Crijns, Harry
Nieman, Fred
Deweerd, Gerjan
Kragten, Johannes
Gorgels, Anton
author_sort Boyne, Josiane
collection PubMed
description BACKGROUND: Recent increasing prevalence of heart failure (HF) patients leads to an increasing burden to the health care system. Consequently, there is a need for innovative strategies to reduce HF hospitalizations. METHODS: We performed a multicentre randomized controlled trial to test the hypothesis that telemonitoring in patients with HF, by means of the Health Buddy(®) system (HB), will reduce HF hospitalizations and number of contacts with caregivers as compared to care as usual (CAU) during 1 year follow-up, from October 1, 2007, through December 31, 2008. RESULTS: Among 382 patients—197 in the HB and 185 in the CAU-group—226 (59%) were male, mean age was 71.5 (SD 11.2), 45.5% being ≥75 years of age; 57% of the patients were in NYHA HF class 2, 40% in class 3 and 3% in class 4. Both study groups were similar for demographic and clinical characteristics. Mean time to first heart failure related hospitalization was 161 days for the intervention group and 139 days for the usual-care group; hospitalizations occurred in 18 (9.1%) compared to 25 patients (13.5%) respectively (Kaplan–Meier p=0.151, hazard ratio 0.65, CI 0.35–1.17). Combined endpoint of heart failure admission and all cause mortality was similar for both groups (Kaplan–Meier p=0.641 hazard ratio 0.89, CI 0.69–1.83). Cox regression analysis disclosed an important interaction between group assignment and heart failure duration, p=0.007, OR=0.983, CI 0.970–0.995 indicating a significant decrease in heart failure hospitalizations in the intervention group if heart failure duration was <18 months, p=0.026, hazard ratio 0.26, CI 0.07–0.94. Contacts with the heart-failure-nurse were mean 1.36 (range 0–11) in the intervention group vs. 1.74 (0–8) in the usual-care group (Mann-Whitney p<0.001). Mortality was 18 (9.1%) in the intervention-group and 12 (6.5%) in the usual-care-group (Mann–Whitney p=0.34, Cox-regression analysis p=0.82). CONCLUSION: Telemonitoring tends to reduce heart failure admissions and decreases contacts with specialized nurses. If heart failure duration is <18 months heart failure admissions and readmissions are significantly reduced.
format Online
Article
Text
id pubmed-3571195
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Igitur, Utrecht Publishing & Archiving
record_format MEDLINE/PubMed
spelling pubmed-35711952013-04-16 Tailored Telemonitoring in patients with heart failure: results from a multicentre randomized controlled trial (the TEHAF-study) Boyne, Josiane Vrijhoef, Hubertus Crijns, Harry Nieman, Fred Deweerd, Gerjan Kragten, Johannes Gorgels, Anton Int J Integr Care Conference Abstract BACKGROUND: Recent increasing prevalence of heart failure (HF) patients leads to an increasing burden to the health care system. Consequently, there is a need for innovative strategies to reduce HF hospitalizations. METHODS: We performed a multicentre randomized controlled trial to test the hypothesis that telemonitoring in patients with HF, by means of the Health Buddy(®) system (HB), will reduce HF hospitalizations and number of contacts with caregivers as compared to care as usual (CAU) during 1 year follow-up, from October 1, 2007, through December 31, 2008. RESULTS: Among 382 patients—197 in the HB and 185 in the CAU-group—226 (59%) were male, mean age was 71.5 (SD 11.2), 45.5% being ≥75 years of age; 57% of the patients were in NYHA HF class 2, 40% in class 3 and 3% in class 4. Both study groups were similar for demographic and clinical characteristics. Mean time to first heart failure related hospitalization was 161 days for the intervention group and 139 days for the usual-care group; hospitalizations occurred in 18 (9.1%) compared to 25 patients (13.5%) respectively (Kaplan–Meier p=0.151, hazard ratio 0.65, CI 0.35–1.17). Combined endpoint of heart failure admission and all cause mortality was similar for both groups (Kaplan–Meier p=0.641 hazard ratio 0.89, CI 0.69–1.83). Cox regression analysis disclosed an important interaction between group assignment and heart failure duration, p=0.007, OR=0.983, CI 0.970–0.995 indicating a significant decrease in heart failure hospitalizations in the intervention group if heart failure duration was <18 months, p=0.026, hazard ratio 0.26, CI 0.07–0.94. Contacts with the heart-failure-nurse were mean 1.36 (range 0–11) in the intervention group vs. 1.74 (0–8) in the usual-care group (Mann-Whitney p<0.001). Mortality was 18 (9.1%) in the intervention-group and 12 (6.5%) in the usual-care-group (Mann–Whitney p=0.34, Cox-regression analysis p=0.82). CONCLUSION: Telemonitoring tends to reduce heart failure admissions and decreases contacts with specialized nurses. If heart failure duration is <18 months heart failure admissions and readmissions are significantly reduced. Igitur, Utrecht Publishing & Archiving 2012-06-15 /pmc/articles/PMC3571195/ Text en Copyright 2012, International Journal of Integrated Care (IJIC) http://creativecommons.org/licenses/by/3.0/ This work is licensed under a (http://creativecommons.org/licenses/by/3.0) Creative Commons Attribution 3.0 Unported License
spellingShingle Conference Abstract
Boyne, Josiane
Vrijhoef, Hubertus
Crijns, Harry
Nieman, Fred
Deweerd, Gerjan
Kragten, Johannes
Gorgels, Anton
Tailored Telemonitoring in patients with heart failure: results from a multicentre randomized controlled trial (the TEHAF-study)
title Tailored Telemonitoring in patients with heart failure: results from a multicentre randomized controlled trial (the TEHAF-study)
title_full Tailored Telemonitoring in patients with heart failure: results from a multicentre randomized controlled trial (the TEHAF-study)
title_fullStr Tailored Telemonitoring in patients with heart failure: results from a multicentre randomized controlled trial (the TEHAF-study)
title_full_unstemmed Tailored Telemonitoring in patients with heart failure: results from a multicentre randomized controlled trial (the TEHAF-study)
title_short Tailored Telemonitoring in patients with heart failure: results from a multicentre randomized controlled trial (the TEHAF-study)
title_sort tailored telemonitoring in patients with heart failure: results from a multicentre randomized controlled trial (the tehaf-study)
topic Conference Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571195/
work_keys_str_mv AT boynejosiane tailoredtelemonitoringinpatientswithheartfailureresultsfromamulticentrerandomizedcontrolledtrialthetehafstudy
AT vrijhoefhubertus tailoredtelemonitoringinpatientswithheartfailureresultsfromamulticentrerandomizedcontrolledtrialthetehafstudy
AT crijnsharry tailoredtelemonitoringinpatientswithheartfailureresultsfromamulticentrerandomizedcontrolledtrialthetehafstudy
AT niemanfred tailoredtelemonitoringinpatientswithheartfailureresultsfromamulticentrerandomizedcontrolledtrialthetehafstudy
AT deweerdgerjan tailoredtelemonitoringinpatientswithheartfailureresultsfromamulticentrerandomizedcontrolledtrialthetehafstudy
AT kragtenjohannes tailoredtelemonitoringinpatientswithheartfailureresultsfromamulticentrerandomizedcontrolledtrialthetehafstudy
AT gorgelsanton tailoredtelemonitoringinpatientswithheartfailureresultsfromamulticentrerandomizedcontrolledtrialthetehafstudy